Sendek Joel 4
4 · Perspective Therapeutics, Inc. · Filed Sep 5, 2025
Insider Transaction Report
Form 4
Sendek Joel
Chief Financial Officer
Transactions
- Award
Stock option (right to buy)
2025-09-04+600,000→ 600,000 totalExercise: $3.54Exp: 2035-09-04→ Common Stock (600,000 underlying)
Footnotes (1)
- [F1]The options vest over a four-year period, with one-fourth (1/4) vesting and becoming exercisable on September 4, 2026, and the remaining options vesting and becoming exercisable ratably over the following 36 months, subject to the continuous service of the Reporting Person as of each vesting date.